{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Germantown",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "90691",
      "recalling_firm": "Qiagen Sciences LLC",
      "address_1": "19300 Germantown Rd",
      "address_2": "",
      "postal_code": "20874-1415",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand",
      "recall_number": "Z-1651-2022",
      "product_description": "therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US)  REF 874711",
      "product_quantity": "29 kits",
      "reason_for_recall": "Increased occurrence rate of false positive results,  lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects",
      "recall_initiation_date": "20220720",
      "center_classification_date": "20220829",
      "report_date": "20220907",
      "code_info": "Lot number:  172017804   Exp Date: 10.11.2022 169046610   Exp. Date: 12.06.2022",
      "more_code_info": ""
    }
  ]
}